Pan-cancer analysis uncovers a new class of promising CAR T--cell immunotherapy targets
Friday, 3 May 2024
St. Jude found 156 potential targets for chimeric antigen receptor (CAR) T--cell immunotherapy. Explore the discovery's promise to improve cancer therapies.
|
||||
You Might Like |
||||
